SCHEMBL8148477

SCHEMBL8148477

COCc1nc(-c2ccccc2)c(-c2ccc(S(N)(=O)=O)cc2)o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 8/20 0.51
PTGS1 P23219 5/20 0.51
CA1 P00915 5/20 0.50
CA2 P00918 5/20 0.50
CA12 O43570 3/20 0.50
CA9 Q16790 3/20 0.50
NR4A2 P43354 7/20 0.48
NR4A1 P22736 2/20 0.48
NR4A3 Q92570 2/20 0.48
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
RXRA P19793 4/20 0.46
RXRB P28702 3/20 0.46
LMNA P02545 2/20 0.46
CYP3A4 P08684 2/20 0.46
CHRM1 P11229 2/20 0.46
MT-CO2 P00403 1/20 0.46
CA3 P07451 1/20 0.46
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8552103 1.00 PTGS2 (0.51) PTGS2PTGS1CA1CA2CA12
SCHEMBL8546102 0.89 PTGS2 (0.66) PTGS2PTGS1CA1CA2CA12
SCHEMBL8552170 0.89 PTGS2 (0.50) PTGS2PTGS1CA1CA2CA12
SCHEMBL8547731 0.89 PTGS2 (0.50) PTGS2PTGS1CA1CA2CA12
SCHEMBL8547060 0.89 PTGS2 (0.50) PTGS2PTGS1CA1CA2CA12
SCHEMBL7502659 0.87 CA1 (0.56) PTGS2PTGS1CA1CA2CA12
SCHEMBL7506158 0.87 CA1 (0.56) PTGS2PTGS1CA1CA2CA12
SCHEMBL8552080 0.87 CA2 (0.52) PTGS2PTGS1CA1CA2CA12
SCHEMBL8552563 0.87 CA2 (0.52) PTGS2PTGS1CA1CA2CA12
SCHEMBL7505499 0.86 PTGS2 (0.54) PTGS2PTGS1CA1CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 EP claimed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 WO claimed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 WO disclosed